Filed before 2025Filed 4 February 2015
Mnemosyne Pharmaceuticals Inc has sold $12.3M so far
Mnemosyne Pharmaceuticals Inc, a biotech company based in Providence, RI, has sold $12.3M so far in its equity round, according to a filing dated 4 February 2015.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 4 February 2015
- First filed
- 16 February 2012
- Round
- Equity round (amended filing)
- Amount sold
- $12.3M
- Offering size
- $13M
- Investors so far
- 6
- Based in
- Providence, RI
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 68% of the 1,574 tracked raises with an amount filed in 2015, and than 58% of the 132 in biotech.
Mnemosyne Pharmaceuticals Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Feb 2015 | Amended filing | $12.3M | This raise |
More with Playground Ventures on the board
- Strand Therapeutics Inc.$108M
- Sizable Energy Inc$8.81M
- Snowcap Compute Inc.$23M
- xLight Inc.$40.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.